RT Journal Article SR Electronic T1 An official European Respiratory Society statement on physical activity in COPD JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP 1521 OP 1537 DO 10.1183/09031936.00046814 VO 44 IS 6 A1 Henrik Watz A1 Fabio Pitta A1 Carolyn L. Rochester A1 Judith Garcia-Aymerich A1 Richard ZuWallack A1 Thierry Troosters A1 Anouk W. Vaes A1 Milo A. Puhan A1 Melissa Jehn A1 Michael I. Polkey A1 Ioannis Vogiatzis A1 Enrico M. Clini A1 Michael Toth A1 Elena Gimeno-Santos A1 Benjamin Waschki A1 Cristobal Esteban A1 Maurice Hayot A1 Richard Casaburi A1 Janos Porszasz A1 Edward McAuley A1 Sally J. Singh A1 Daniel Langer A1 Emiel F.M. Wouters A1 Helgo Magnussen A1 Martijn A. Spruit YR 2014 UL http://erj.ersjournals.com/content/44/6/1521.abstract AB This European Respiratory Society (ERS) statement provides a comprehensive overview on physical activity in patients with chronic obstructive pulmonary disease (COPD). A multidisciplinary Task Force of experts representing the ERS Scientific Group 01.02 “Rehabilitation and Chronic Care” determined the overall scope of this statement through consensus. Focused literature reviews were conducted in key topic areas and the final content of this Statement was agreed upon by all members. The current knowledge regarding physical activity in COPD is presented, including the definition of physical activity, the consequences of physical inactivity on lung function decline and COPD incidence, physical activity assessment, prevalence of physical inactivity in COPD, clinical correlates of physical activity, effects of physical inactivity on hospitalisations and mortality, and treatment strategies to improve physical activity in patients with COPD. This Task Force identified multiple major areas of research that need to be addressed further in the coming years. These include, but are not limited to, the disease-modifying potential of increased physical activity, and to further understand how improvements in exercise capacity, dyspnoea and self-efficacy following interventions may translate into increased physical activity. The Task Force recommends that this ERS statement should be reviewed periodically (e.g. every 5–8 years). An official ERS statement providing a comprehensive overview on physical activity in patients with COPD http://ow.ly/C6v78